Top Banner
Bad LV and severe MR: How to proceed and how to predict LV improvement? Jan Vontobel, MD Heart Failure/Transplant St Paul‘s Hospital, Vancouver Canada
35

Bad LV and severe MR: How to proceed and how to predict LV ... · Preoperative predictors of secondary recurrent MR after undersized annuloplasty: LVEDD > 65mm Post. Mitral leaflet

Oct 23, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • Bad LV and severe MR:

    How to proceed and how to

    predict LV improvement?

    Jan Vontobel, MD

    Heart Failure/Transplant

    St Paul‘s Hospital, Vancouver

    Canada

  • Conflict of interest

    Travel Grant by St. Jude Medical

  • outline

    Different Treatment options

    Unresolved Questions

    Impact of MR on prognosis

    Etiologies of MR

    Prevalence of valvular heart disease

    Mitral Valve Anatomy

  • Mitral valve anatomy

  • Prevalence of valvular heart disease

    V. Nkomo. Lancet 2006;368:1005-11

  • Etiology of MR

    Mechanism:Carpentier II

    (Exessive leafletmotion or prolaps)

    Mechanism:Carpentier I + III

    (anular dilatation andrestrictive leaflet

    motion)

  • Echo criteria of severe MR

    Vahanian. Eur Hear J 2012;33:2451-2496

  • Survival Probability in CHF

    according to the degree of MR

    B. Trichon. Am J Car 2003;91:538-543

  • Survival free of heart failure

    according to the degree of MR

    F. Bursi. Circ. 2005;111:295-301

    35% free of

    HF

    84%

    74%

  • Medical Therapy of Mitral Regurgitation

    H. Levine. J Am Coll Cardiol. 1996;28:1083-91

    Volume

    Pre

    ssu

    re

    ∆V

    ∆P

    EF 50% EF 30%

  • Medical Therapy of FMR

    H. Levine. J Am Coll Cardiol. 1996;28:1083-91

  • Medical Therapy of FMR

    H. Levine. J Am Coll Cardiol. 1996;28:1083-91

  • Medical Therapy of FMR

    B. Lowes. Am J Cardiol. 1999;83:1201-1205

  • N. Bellenger, Heart 2004;90:760-765

  • CRT in FMR

    R. van Bommel. Circ. 2011;124:912-919

    LVEF 23% ±7%

    MR improvers

    MR non-improvers

    Surv

    ival

    Follow-up (months)

  • Guidelines in FMR

    Indications for mitralValve surgery in chronicsecondaryMitral regurgitation

    European Heart Failure Guidelines, 2016

  • Surgery in FMR

    A.Ciarka, Am J Cariol. 2010;106:395-401

    Preoperative predictors of secondary recurrent MR after undersized

    annuloplasty:

    LVEDD > 65mm

    Post. Mitral leaflet angle > 45°

    Distal anterior mitral leaflet angle > 25°

    Systolic tenting area > 2.5cm2

    Coaptation distance > 10mm

    End-systolic interpapillary muscle distance > 20mm

    Systolic spericity index > 0.7

  • Surgery in FMR

    M. Acker, N Engl J Med. 2014; 370:23-32

  • Surgery in FMR

    Severe MR

    Moderate MR30%

    20%

    10%

    2.3%

    28.4%

    4.2%

    32.6%

    repair Replacement at 12months

    M. Acker, N Engl J Med. 2014; 370:23-32

  • Euro Heart Survey

    M. Mirabel, Eur Heart J. 2007; 28:1358-1365

    5001 patients with valvular heart disease included:

    - 33.6% Mitral regurgitation

    51.3% of symptomaticpatients with severe MR were

    denied surgery

  • Mitra Clip anatomical Considerations

    Wunderlich, Eur Heart J. CVI 2013

  • Current evidence for Mitra Clip use

    M. Taramasso, Cardiovasc. Med. 2015; 18:333-339

    FIRST-

    IN-MAN

    RCT’S

    REGIS-

    TRIES

    META-

    ANA-

    LYSES

    EVEREST IN=55

    TRAMI n=1,064

    Pilot Eur.SentinelN=628

    ACCESS-Europe†n=567

    EVEREST HRR†N=78

    Vakil

    N=2,980

    REALISM† (ongoing) n>300

    GRASP n>117 (ongoing)

    MitraSwiss n>500

    CE Mark (march 2008)

    EVEREST II roll-inN=52

    EVEREST II N=279

    RESHAPE

    COAPT

    D’Ascenzo

    N=875

    Philip

    N=3,198

    Wan

    N=349

    Munkholm

    N=878

    MATTER-

    HORN

    MITRA-FRHIRIDE

    **for degenerative MR with prohibitive surgical risk

    † industry-sponsored registries

    ǀ ǀ ǀ ǀ ǀ ǀ ǀ ǀ ǀ ǀ ǀ ǀ ǀ

    2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

    https://en.wikipedia.org/wiki/File:Flag_of_Italy.svghttps://en.wikipedia.org/wiki/File:Flag_of_Italy.svghttp://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAcQjRxqFQoTCI-Mz-zbk8YCFc4g2wodzvQAkg&url=http://commons.wikimedia.org/wiki/File:Flag_of_Switzerland_(Pantone).svg&ei=zdN_Vc_xA87B7AbO6YOQCQ&bvm=bv.96041959,d.d24&psig=AFQjCNGEjGRE9ZqZq-OMgz4lYNfOxxn-Eg&ust=1434527051379280http://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAcQjRxqFQoTCI-Mz-zbk8YCFc4g2wodzvQAkg&url=http://commons.wikimedia.org/wiki/File:Flag_of_Switzerland_(Pantone).svg&ei=zdN_Vc_xA87B7AbO6YOQCQ&bvm=bv.96041959,d.d24&psig=AFQjCNGEjGRE9ZqZq-OMgz4lYNfOxxn-Eg&ust=1434527051379280http://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAMQjRxqFQoTCMjc7rvek8YCFQGWLAod8e0PcQ&url=http://en.wikipedia.org/wiki/Flag_of_Germany&ei=jNZ_VcjmB4GssgHx27-IBw&bvm=bv.96041959,d.bGg&psig=AFQjCNELpbaoVerdeFWhg6oTdW3GJY7WLw&ust=1434527756167038http://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAMQjRxqFQoTCMjc7rvek8YCFQGWLAod8e0PcQ&url=http://en.wikipedia.org/wiki/Flag_of_Germany&ei=jNZ_VcjmB4GssgHx27-IBw&bvm=bv.96041959,d.bGg&psig=AFQjCNELpbaoVerdeFWhg6oTdW3GJY7WLw&ust=1434527756167038http://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAMQjRxqFQoTCMjc7rvek8YCFQGWLAod8e0PcQ&url=http://en.wikipedia.org/wiki/Flag_of_Germany&ei=jNZ_VcjmB4GssgHx27-IBw&bvm=bv.96041959,d.bGg&psig=AFQjCNELpbaoVerdeFWhg6oTdW3GJY7WLw&ust=1434527756167038http://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAMQjRxqFQoTCMjc7rvek8YCFQGWLAod8e0PcQ&url=http://en.wikipedia.org/wiki/Flag_of_Germany&ei=jNZ_VcjmB4GssgHx27-IBw&bvm=bv.96041959,d.bGg&psig=AFQjCNELpbaoVerdeFWhg6oTdW3GJY7WLw&ust=1434527756167038http://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAcQjRxqFQoTCKSqhbGPlMYCFWWPcgodzuIACQ&url=http://en.wikipedia.org/?title=Flag_of_France&ei=1gmAVaTnLuWeygPOxYNI&bvm=bv.96041959,d.bGg&psig=AFQjCNFhnCT9kjjS7R-rd6LIyj33wBrL3g&ust=1434540881426074http://www.google.ch/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAcQjRxqFQoTCKSqhbGPlMYCFWWPcgodzuIACQ&url=http://en.wikipedia.org/?title=Flag_of_France&ei=1gmAVaTnLuWeygPOxYNI&bvm=bv.96041959,d.bGg&psig=AFQjCNFhnCT9kjjS7R-rd6LIyj33wBrL3g&ust=1434540881426074

  • Reduction in MR and LV/LA Remodeling

    P. Grayburn, Circ. 2013; 128:1667-1674

  • Usefulness of MitraClip in FMR

    F. D’Ascenzo, Am J Cardiol. 2015; 116:325-331

  • Unanswered Questions

    Does MitraClip compared to Optimal Medical Treatment improve the prognosis of thepatients?

    Is the Mitral Regurgitation itself independently and prognostically causative relevant or isit just a Bystander?

    Randomized Controlled Trials are needed - COAP Trial

    Predictive parameters of outcome in medical as well as interventional treatmentsTime of referral?

  • At present what to do in FMR

    Optimal Medical Therapy

    CRT where indicated

    Surgery if CABG and LVEF>30%; LVEF 1year

  • M. Taramasso, Cardiovasc. Med. 2015; 18:333-339

  • Guidelines in FMR

    European Guidelines on the management of valvular heart disease, 2012

    Indications for mitralValve surgery in chronicsecondaryMitral regurgitation

    European Guidelines on myocardial revascularization, 2014

    European Heart Failure Guidelines, 2016

  • EVEREST II HRR or REALISM HR

    D. Glower, JACC. 2014; 64:172-81

  • Medical Therapy of FMR

    H. Okura. Heart. 2016;10

    EF≥50% EF≤50%